Des traitements expérimentaux, comme la thérapie génique, sont en cours d'évaluation.
Thérapie géniqueTraitements expérimentaux
#4
Les traitements sont-ils personnalisés ?
Oui, les traitements peuvent être adaptés en fonction des besoins individuels du patient.
Médecine personnaliséeAdaptation du traitement
#5
Quel rôle joue la rééducation dans le traitement ?
La rééducation est essentielle pour améliorer la fonction et la qualité de vie des patients.
RééducationFonction
Complications
5
#1
Quelles complications peuvent survenir avec des troubles gliaux ?
Les complications incluent des troubles cognitifs, des crises épileptiques et des troubles de l'humeur.
Troubles cognitifsCrises épileptiques
#2
Les complications sont-elles réversibles ?
Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non.
RéversibilitéTraitement approprié
#3
Comment les complications affectent-elles le quotidien ?
Elles peuvent entraîner des limitations dans les activités quotidiennes et la vie sociale.
Activités quotidiennesVie sociale
#4
Y a-t-il des risques de complications à long terme ?
Oui, des complications à long terme peuvent survenir, affectant la santé mentale et physique.
Risques à long termeSanté mentale
#5
Les complications nécessitent-elles une surveillance continue ?
Oui, une surveillance régulière est essentielle pour gérer les complications et ajuster le traitement.
SurveillanceGestion des complications
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque pour les troubles gliaux ?
Les facteurs de risque incluent des antécédents familiaux, des infections et des traumatismes crâniens.
Antécédents familiauxTraumatismes crâniens
#2
L'âge est-il un facteur de risque ?
Oui, certains troubles gliaux sont plus fréquents chez les personnes âgées ou les jeunes enfants.
ÂgeTroubles gliaux
#3
Le mode de vie influence-t-il les risques ?
Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter les risques.
Mode de vieAlimentation
#4
Les maladies auto-immunes sont-elles un facteur de risque ?
Oui, certaines maladies auto-immunes peuvent affecter la fonction gliale et augmenter les risques.
Maladies auto-immunesFonction gliale
#5
Y a-t-il des facteurs génétiques impliqués ?
Oui, des mutations génétiques peuvent prédisposer certains individus à des troubles gliaux.
Facteurs génétiquesMutations
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteur de maturation gliale : Questions médicales les plus fréquentes",
"headline": "Facteur de maturation gliale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteur de maturation gliale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-02",
"dateModified": "2025-04-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteur de maturation gliale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Facteurs de croissance nerveuse",
"url": "https://questionsmedicales.fr/mesh/D009414",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de croissance nerveuse",
"code": {
"@type": "MedicalCode",
"code": "D009414",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.850"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Facteur de maturation gliale",
"alternateName": "Glia Maturation Factor",
"code": {
"@type": "MedicalCode",
"code": "D020904",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Duraisamy Kempuraj",
"url": "https://questionsmedicales.fr/author/Duraisamy%20Kempuraj",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, and the Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA."
}
},
{
"@type": "Person",
"name": "Ramasamy Thangavel",
"url": "https://questionsmedicales.fr/author/Ramasamy%20Thangavel",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, and the Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA."
}
},
{
"@type": "Person",
"name": "Mohammad Ejaz Ahmed",
"url": "https://questionsmedicales.fr/author/Mohammad%20Ejaz%20Ahmed",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, and the Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA."
}
},
{
"@type": "Person",
"name": "Govindhasamy Pushpavathi Selvakumar",
"url": "https://questionsmedicales.fr/author/Govindhasamy%20Pushpavathi%20Selvakumar",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, and the Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA."
}
},
{
"@type": "Person",
"name": "Sudhanshu P Raikwar",
"url": "https://questionsmedicales.fr/author/Sudhanshu%20P%20Raikwar",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, and the Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Progress and Persistent Disparities in Patient Access to Electronic Health Information.",
"datePublished": "2023-11-03",
"url": "https://questionsmedicales.fr/article/37948063",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamahealthforum.2023.3883"
}
},
{
"@type": "ScholarlyArticle",
"name": "Disparate impacts on online information access during the Covid-19 pandemic.",
"datePublished": "2022-11-19",
"url": "https://questionsmedicales.fr/article/36402817",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-022-34592-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Access to information on sustainable intensification practices for new agricultural business entities in China.",
"datePublished": "2022-11-16",
"url": "https://questionsmedicales.fr/article/36380182",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11356-022-24158-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Utility and usability evaluation of an information diary tool to measure health information access and exposure among patients with high cardiovascular risk.",
"datePublished": "2023-05-09",
"url": "https://questionsmedicales.fr/article/37228723",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2023.1132397"
}
},
{
"@type": "ScholarlyArticle",
"name": "Access to information on oral hygiene and mothers' practices of children with microcephaly caused by Zika virus.",
"datePublished": "2022-09-11",
"url": "https://questionsmedicales.fr/article/36048965",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/idh.12618"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Facteurs de croissance nerveuse",
"item": "https://questionsmedicales.fr/mesh/D009414"
},
{
"@type": "ListItem",
"position": 5,
"name": "Facteur de maturation gliale",
"item": "https://questionsmedicales.fr/mesh/D020904"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteur de maturation gliale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteur de maturation gliale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteur de maturation gliale",
"description": "Comment diagnostiquer une anomalie des facteurs de maturation gliale ?\nQuels tests sont utilisés pour évaluer les facteurs gliaux ?\nLes facteurs de maturation gliale sont-ils mesurables ?\nQuels signes cliniques indiquent un problème glial ?\nLes tests génétiques sont-ils utiles pour ces facteurs ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Access+to+Information#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteur de maturation gliale",
"description": "Quels symptômes sont liés à une dysfonction gliale ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes physiques associés ?\nLes symptômes sont-ils réversibles ?\nComment les symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Access+to+Information#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteur de maturation gliale",
"description": "Peut-on prévenir les troubles liés aux facteurs gliaux ?\nY a-t-il des facteurs environnementaux à éviter ?\nL'éducation joue-t-elle un rôle dans la prévention ?\nLes vaccinations peuvent-elles prévenir des troubles gliaux ?\nLe soutien psychologique est-il préventif ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Access+to+Information#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteur de maturation gliale",
"description": "Quels traitements sont disponibles pour les troubles gliaux ?\nLes thérapies comportementales sont-elles efficaces ?\nY a-t-il des traitements expérimentaux ?\nLes traitements sont-ils personnalisés ?\nQuel rôle joue la rééducation dans le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Access+to+Information#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteur de maturation gliale",
"description": "Quelles complications peuvent survenir avec des troubles gliaux ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles le quotidien ?\nY a-t-il des risques de complications à long terme ?\nLes complications nécessitent-elles une surveillance continue ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Access+to+Information#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteur de maturation gliale",
"description": "Quels sont les principaux facteurs de risque pour les troubles gliaux ?\nL'âge est-il un facteur de risque ?\nLe mode de vie influence-t-il les risques ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nY a-t-il des facteurs génétiques impliqués ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Access+to+Information#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des facteurs de maturation gliale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques et des analyses histologiques des tissus nerveux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les facteurs gliaux ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie cérébrale et des biopsies peuvent être utilisés pour évaluer les facteurs gliaux."
}
},
{
"@type": "Question",
"name": "Les facteurs de maturation gliale sont-ils mesurables ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dosages spécifiques dans le liquide céphalorachidien peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un problème glial ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques, des déficits cognitifs ou des symptômes psychiatriques peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour ces facteurs ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations associées aux anomalies des facteurs gliaux."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une dysfonction gliale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles de la mémoire, des convulsions et des changements de comportement."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et du stade de développement neurologique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes physiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes physiques comme des douleurs ou des faiblesses musculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la cause sous-jacente; certains symptômes peuvent être réversibles avec un traitement."
}
},
{
"@type": "Question",
"name": "Comment les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent gravement affecter la qualité de vie, entraînant des limitations fonctionnelles et sociales."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux facteurs gliaux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures préventives, comme une bonne nutrition et l'exercice, peuvent aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à éviter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines et à des infections peut augmenter le risque de troubles gliaux."
}
},
{
"@type": "Question",
"name": "L'éducation joue-t-elle un rôle dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les signes précoces peut aider à une intervention rapide et efficace."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir des troubles gliaux ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui affectent le système nerveux."
}
},
{
"@type": "Question",
"name": "Le soutien psychologique est-il préventif ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien psychologique peut réduire le stress et améliorer la résilience face aux troubles."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles gliaux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, la thérapie physique et des interventions chirurgicales si nécessaire."
}
},
{
"@type": "Question",
"name": "Les thérapies comportementales sont-elles efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent aider à gérer les symptômes psychiatriques associés aux troubles gliaux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux, comme la thérapie génique, sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des besoins individuels du patient."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la rééducation dans le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La rééducation est essentielle pour améliorer la fonction et la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des troubles gliaux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles cognitifs, des crises épileptiques et des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles le quotidien ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des limitations dans les activités quotidiennes et la vie sociale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications à long terme peuvent survenir, affectant la santé mentale et physique."
}
},
{
"@type": "Question",
"name": "Les complications nécessitent-elles une surveillance continue ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière est essentielle pour gérer les complications et ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les troubles gliaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent des antécédents familiaux, des infections et des traumatismes crâniens."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles gliaux sont plus fréquents chez les personnes âgées ou les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il les risques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent affecter la fonction gliale et augmenter les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs génétiques impliqués ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations génétiques peuvent prédisposer certains individus à des troubles gliaux."
}
}
]
}
]
}
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Pharmacology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Patient access to electronic health information (EHI) available via online medical records and through patient portals has been shown to help individuals make informed health decisions, which are asso...
To assess progress in patient engagement with EHI and to identify racial or ethnic disparities in access to patient portals....
This was a repeated cross-sectional study using data from the US Health Information National Trends Survey (HINTS), a nationally representative survey of US adults that tracks individuals' access and ...
Patient reports of (1) being offered portal access by a health care provider (HCP); (2) being encouraged by the HCP to use the portal; (3) accessing their portal; and (4) using the portal for various ...
The total study population included 22 266 individuals (mean [SE] age, 49.9 [0.15] years) of whom 13 348 (54%) were female; 909 (5%) self-identified as Asian, 3523 (12%) as Black, 3178 (14%) as Hispan...
The findings of this repeated cross-sectional study of US adult respondents to the HINTS suggest that access to and engagement with patient portals increased significantly from 2014 through 2022, but ...
The COVID-19 pandemic has stimulated important changes in online information access as digital engagement became necessary to meet the demand for health, economic, and educational resources. Our analy...
The adoption of sustainable intensification practices (SIPs) is generally lagging in China, as disseminating new technology to millions of farmers on heterogeneous smallholdings is challenging. Agricu...
Online health misinformation about statins potentially affects health decision-making on statin use and adherence. We developed an information diary platform (IDP) to measure topic-specific health inf...
We used a mixed-method design to evaluate how participants used the smartphone diary tool and their perspectives on usability. Participants were high cardiovascular-risk patients recruited from a prim...
The information diary was available in three languages and tested with 24 participants. The mean SUS score was 69.8 ± 12.9. Five themes related to utility were: IDP functions as a health information d...
We found that the smartphone diary can be used as a research instrument to record relevant examples of information exposure. It potentially modifies how people seek and appraise topic-specific health ...
To verify whether access to information about oral hygiene influenced the practices of caregivers of children with microcephaly caused by Zika virus (ZIKV)....
A case series study was developed at the Mens Sana Rehabilitation Center, in the municipality of Arcoverde, Pernambuco, Brazil. The study universe included the mothers of 32 children with microcephaly...
Out of 32 individuals eligible to participate in the study, only 27 were selected. Most mothers reported receiving information about oral hygiene from their infants (63.0%). Fisher's Exact and Pearson...
Access to information about oral hygiene positively influenced the oral health care of mothers with their children with microcephaly caused by ZIKV....
Non-menopausal women with breast cancer treated with chemotherapy are at intermediate risk of post-treatment amenorrhea and decreased fertility. Although they should receive appropriate information, s...
People with cervical spinal cord injury (SCI) identify improving upper extremity (UE) function as a top priority. In addition to comprehensive rehabilitation, UE surgeries, including nerve and tendon ...
To assess the experiences and preferences of people with cervical SCI and their caregivers in accessing information about surgery to enhance UE function....
Prospective cohort study. Participants were followed up for 24 months and completed up to three interviews....
Tertiary care at academic and affiliated Veterans Administration Health Care Centers....
Adults with cervical SCI (n = 35) ages 18 to 80 years with mid-cervical SCI American Spinal Injury Association Impairment Scale A, B, or C (at least 6 months post-injury) and their caregivers (n = 23)...
Not applicable....
Semi-structured interviews about surgical knowledge and experiences....
Data were analyzed and three themes were identified. First, providing information about UE surgical options early post-injury was recommended. The acute or inpatient rehabilitation phases of recovery ...
Following cervical SCI, information about UE reconstructive surgeries should be a standard component of education during rehabilitation. An increased understanding of the reconstructive options availa...
Population aging is a major concern worldwide. Active aging should be promoted by increasing the social participation of older adults and enabling them to remain involved in the community. Research ha...
Telehealth is increasingly used to deliver mental health services. However, the potential benefits of telehealth for people with intellectual and developmental disabilities and mental health needs (ID...
What factors are associated with access to ICTs among family caregivers of people with IDD-MH who use START services?...
Retrospective analysis of cross-sectional interview data gathered for START use at the onset of COVID-19. START is a crisis prevention and intervention evidence-based model for people with IDD-MH impl...
Age (ages 23-30 years) and sole caregiver status were significantly associated with limited access (both p ≤ .001). Age (ages 23-30 years and ≥31 years, p < .001), race (Black or African American, p =...
Disparities existed in ICT access for adults, specific racial/ethnic groups, and sole caregiver households. Healthcare policy related to telehealth must consider how ICT access can be equitable for al...
Low English language literacy is a common barrier to participation in clinical trials. Patient information leaflets (PILs) used in clinical trials are often lengthy, complex and have poor readability;...
A literature review of MEDLINE, Embase and online resources was conducted, and recommendations for developing accessible PILs were extracted from eligible published and grey literature. Grey literatur...
The framework consists of 74 recommendations for developing accessible PILs for clinical trials. Recommendations cover the five topics of formatting, information presentation, writing style, content a...
This project has developed a comprehensive framework of recommendations to guide researchers in the development of accessible PILs for clinical trials. Findings from previous research and from co-work...